These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25339776)

  • 1. Identification of capsid mutations that alter the rate of HIV-1 uncoating in infected cells.
    Hulme AE; Kelley Z; Okocha EA; Hope TJ
    J Virol; 2015 Jan; 89(1):643-51. PubMed ID: 25339776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HIV-1 uncoating in human microglial cell lines.
    Ingram Z; Taylor M; Okland G; Martin R; Hulme AE
    Virol J; 2020 Mar; 17(1):31. PubMed ID: 32143686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary Assays Reveal a Low Level of CA Associated with Viral Complexes in the Nuclei of HIV-1-Infected Cells.
    Hulme AE; Kelley Z; Foley D; Hope TJ
    J Virol; 2015 May; 89(10):5350-61. PubMed ID: 25741002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-site suppressors of HIV-1 capsid mutations: restoration of intracellular activities without correction of intrinsic capsid stability defects.
    Yang R; Shi J; Byeon IJ; Ahn J; Sheehan JH; Meiler J; Gronenborn AM; Aiken C
    Retrovirology; 2012 Apr; 9():30. PubMed ID: 22515365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription.
    Hulme AE; Perez O; Hope TJ
    Proc Natl Acad Sci U S A; 2011 Jun; 108(24):9975-80. PubMed ID: 21628558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
    Briones MS; Dobard CW; Chow SA
    J Virol; 2010 May; 84(10):5181-90. PubMed ID: 20219923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the mechanical properties of wild type and hyperstable mutants of the HIV-1 capsid.
    Ramalho R; Rankovic S; Zhou J; Aiken C; Rousso I
    Retrovirology; 2016 Mar; 13():17. PubMed ID: 26979152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple Pathways To Avoid Beta Interferon Sensitivity of HIV-1 by Mutations in Capsid.
    Sultana T; Mamede JI; Saito A; Ode H; Nohata K; Cohen R; Nakayama EE; Iwatani Y; Yamashita M; Hope TJ; Shioda T
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
    Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
    J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 uncoating is facilitated by dynein and kinesin 1.
    Lukic Z; Dharan A; Fricke T; Diaz-Griffero F; Campbell EM
    J Virol; 2014 Dec; 88(23):13613-25. PubMed ID: 25231297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cyclosporin A washout assay to detect HIV-1 uncoating in infected cells.
    Hulme AE; Hope TJ
    Methods Mol Biol; 2014; 1087():37-46. PubMed ID: 24158812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
    Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
    J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single HIV-1 Imaging Reveals Progression of Infection through CA-Dependent Steps of Docking at the Nuclear Pore, Uncoating, and Nuclear Transport.
    Francis AC; Melikyan GB
    Cell Host Microbe; 2018 Apr; 23(4):536-548.e6. PubMed ID: 29649444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells.
    Müller TG; Zila V; Peters K; Schifferdecker S; Stanic M; Lucic B; Laketa V; Lusic M; Müller B; Kräusslich HG
    Elife; 2021 Apr; 10():. PubMed ID: 33904396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compensatory substitutions in the HIV-1 capsid reduce the fitness cost associated with resistance to a capsid-targeting small-molecule inhibitor.
    Shi J; Zhou J; Halambage UD; Shah VB; Burse MJ; Wu H; Blair WS; Butler SL; Aiken C
    J Virol; 2015 Jan; 89(1):208-19. PubMed ID: 25320302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA.
    Yang R; Aiken C
    J Virol; 2007 Apr; 81(8):3749-56. PubMed ID: 17267487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclophilin A promotes HIV-1 reverse transcription but its effect on transduction correlates best with its effect on nuclear entry of viral cDNA.
    De Iaco A; Luban J
    Retrovirology; 2014 Jan; 11():11. PubMed ID: 24479545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of capsid mutations on HIV-1 uncoating.
    Wacharapornin P; Lauhakirti D; Auewarakul P
    Virology; 2007 Feb; 358(1):48-54. PubMed ID: 16996553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CA Mutation N57A Has Distinct Strain-Specific HIV-1 Capsid Uncoating and Infectivity Phenotypes.
    Fischer DK; Saito A; Kline C; Cohen R; Watkins SC; Yamashita M; Ambrose Z
    J Virol; 2019 May; 93(9):. PubMed ID: 30814280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capsid Lattice Destabilization Leads to Premature Loss of the Viral Genome and Integrase Enzyme during HIV-1 Infection.
    Eschbach JE; Elliott JL; Li W; Zadrozny KK; Davis K; Mohammed SJ; Lawson DQ; Pornillos O; Engelman AN; Kutluay SB
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.